Last edition
News about "Indoco Remedies"
Indoco Remedies Secures US FDA Approval for Generic Brivaracetam Oral Solution
Indoco Remedies receives US FDA approval to market generic brivaracetam oral solution for partial-onset seizures in the US market.
Indoco Remedies | 24/02/2026 | By News Bureau
Indoco Receives USFDA EIR for Patalganga API Manufacturing Facility
Indoco has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration for its API manufacturing facility at Patalganga following an inspection conducted in the month of September.
Indoco Remedies | 15/12/2025 | By News Bureau | 119
USFDA Completes Inspection of Indoco API Plant in Patalganga with Zero Observations
The inspection of Indoco’s API manufacturing facility at Patalganga by the US FDA concluded with zero form 483 observations.
Indoco Remedies | 22/09/2025 | By Dineshwori | 180
Indoco Remedies Signs Sale and Lease Agreement with OPC Asset Solution
Indoco has signed an agreement with OPC Asset Solution for the sale and subsequent leaseback of certain movable properties at its Waluj Facility in Aurangabad and its AnaCipher Clinical Research Organisation (CRO) in Hyderabad, Telangana.
Indoco Remedies | 30/08/2025 | By Dineshwori | 167
Indoco Remedies Ltd. has received EU GMP certification from the European Health Authorities for its sterile drug manufacturing facility located in South Goa – Goa Plant II.
Indoco Remedies | 24/07/2025 | By Mrinmoy Dey | 296
Alembic Pharma Appoints Dr. Sachin Ghosalkar as Senior VP - SCM and Operations
Alembic Pharmaceuticals Ltd. has announced the appointment of Dr. Sachin Ghosalkar as Senior Vice President – Supply Chain Management (SCM) and Operations, designated as Senior Management Personnel of the company.
Indoco Remedies | 21/07/2025 | By Dineshwori | 339
Indoco Remedies Ltd's Sterlie Facility at Goa receives Form 483 with 4 observations from USFDA
The United States Food and Drug Administration (USFDA) had inspected Indoco Remedies Limited's Sterile Facility (Plant II) located at Goa("Facility"), from February 20, 2023 to February 28, 2023.
Indoco Remedies | 06/06/2023 | By Sudeep Soparkar | 799
US FDA inspects Indoco Remedies' solid oral formulation facility in Goa
The inspection was conducted from January 16 to 20, 2023
Indoco Remedies | 24/01/2023 | By Sudeep Soparkar | 611
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy